Certara Q3 Earnings Call Highlights

Certara reported Q3 bookings up 4% to $92.5M, with a net loss of $3.6M. The company is accelerating cloud conversions and AI integration, expecting growth impacts in 2027. It narrowed FY2026 revenue growth outlook to 2-3% and updated adjusted earnings outlook to $0.31-$0.34 per share. Certara has $214.9M in cash and $100M available under its revolving credit facility.

Original reporting
Published Nov 5, 2026, 7:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 7:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Certara Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$CERTBearishHigh
01

Why it matters

The earnings release narrows growth expectations and signals a near‑term revenue headwind from cloud migration, likely prompting a short‑term price decline.

02

Market read

First‑report earnings with revised guidance; relevant for biotech software investors.

03

What to watch

Cash position of $214.9M and ongoing credit facilities provide financial flexibility despite short‑term guidance weakness.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Certara (NASDAQ:CERT) provides software and services for drug development, reporting Q3 results and updated 2026 guidance.

Company-level read

Ticker impact

$CERTBearishHigh confidence
Context

Q3 earnings report shows narrowed 2026 revenue growth outlook to 2%-3% and adjusted earnings guidance of $0.31-$0.34 per share.

Expected impact

likely pressure as the market prices in weaker revenue growth and earnings outlook

Evidence & confidence

The company cut its full‑year revenue growth outlook and provided modest earnings guidance, which typically triggers a sell‑off in the short term.

Market effects

Software and services for drug development may see broader scrutiny as peers evaluate similar guidance trends.

Limited to U.S. biotech and pharma software niche; no broad regional effect.

Minor, confined to investors tracking quantitative modeling and regulatory software providers.

Counterpoint

The cloud conversion and AI initiatives could unlock higher-margin recurring revenue in 2027, offering a longer‑term upside.

Key entities

  • Resnick

    CEO who discussed earnings and cloud conversion plans.

  • Faiz Mohammed

    Interim CFO who presented the financial details.

Related articles

$CERTMedAI 8/10

An Idle Mill and Old Open Pits Draw a New Plan in Southern Argentina

Cerrado Gold Inc. (TSX.V: CERT) (OTCQX: CRDOF) acquired a past-producing mine in Argentina for $20M, aiming to restart operations by 2027. The mine previously produced 1.4M gold equivalent ounces, with peak output of 137,500 ounces in 2011. The company plans a $40,000m drill program for a resource estimate, funded by its existing Santa Cruz operation.

$CERTHigh

Certara Software Revenue Jumps 11% as Services Decline

Certara Inc. (CERT) reported Q3 2026 software revenue growth of 11% to $48.8M, while services revenue declined 2% to $46.1M. Total revenue rose 4% to $94.9M, and net loss narrowed to $3.6M. Adjusted EBITDA increased 6% to $30.2M. The company maintained its full-year revenue growth forecast of 2-3% and updated its adjusted earnings outlook to 31-34 cents per share.

$CERTMed

Why Did Certara (CERT) Shares Climb After Its Latest Update?

Certara (CERT) reported Q3 2026 revenue of $94.9M, up from $90.89M a year earlier, with net income of $5.59M. However, nine-month revenue of $282.26M showed a net loss of $58.44M. Shares rose 9.83% in one day and 35.94% in 30 days, with a year-to-date return of 39.36%. The company's fair value is estimated at $8.71, suggesting a 40% overvaluation. Certara's AI-driven platforms and acquisitions aim to boost revenue and margins.

$CERTMed

Certara Inc (CERT) Q3 2026 Earnings Call Highlights: Software Growth Accelerates as Margins Expand

Certara Inc (CERT) reported Q3 2026 earnings with software revenue growth of 11% but services revenue declined 2% YoY to $46.1M. Full-year 2026 revenue growth guidance was narrowed to 2%-3%. CEO Jon Resnick highlighted cost savings exceeding $12M and strong software demand across customer tiers. The company is transitioning to a cloud-based model and investing in AI initiatives, expecting growth in 2027. GAAP net loss was $3.6M, and adjusted EPS remained flat at $0.09 YoY.

$CERTMed

Certara, Inc. Q3 2026 Earnings Call Summary

Certara reported 11% organic software revenue growth in Q3 2026, its first double-digit increase in two years. The company divested its Regulatory and Medical Writing business to focus on high-growth areas and reorganized operations. Management expects 2%-3% full-year revenue growth, with software outperforming services. AI capabilities and APAC market expansion are seen as growth drivers for 2027.